机译:一项小规模研究表明,MELD评分和AST /血小板比率指数可预测非移植治疗后小肝癌患者的长期存活率
[1]Tripler Army Medical Center,Surgery,Honolulu,HI96813,USA;
[2]Department of Medicine,John A.Burns School of Medicine,Honolulu,HI96813,USA;
[3]Department of Surgery,John A.Burns School of Medicine,Honolulu,HI96813,USA.;
Hepatocellular carcinoma; ablation; liver resection; transplant;